BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7978053)

  • 21. Tumor-specific mutations in p53: the acid test.
    Hainaut P
    Nat Med; 2002 Jan; 8(1):21-3. PubMed ID: 11786899
    [No Abstract]   [Full Text] [Related]  

  • 22. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
    Kovar H; Auinger A; Jug G; Müller T; Pillwein K
    Oncogene; 1992 Nov; 7(11):2169-73. PubMed ID: 1359493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double germline mutations in the APC and p53 genes.
    Zajac V; Tomka M; Ilenciková D; Májek P; Stevurková V; Kirchhoff T
    Neoplasma; 2000; 47(6):335-41. PubMed ID: 11263856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Yu KK; Zanation AM; Moss JR; Yarbrough WG
    Laryngoscope; 2002 Sep; 112(9):1587-93. PubMed ID: 12352668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
    Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
    J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.
    Warren W; Eeles RA; Ponder BA; Easton DF; Averill D; Ponder MA; Anderson K; Evans AM; DeMars R; Love R
    Oncogene; 1992 May; 7(5):1043-6. PubMed ID: 1570151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation.
    Courtney R; Ranganathan S
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):215-8. PubMed ID: 25374282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
    Bendig I; Mohr N; Kramer F; Weber BH
    Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer.
    Brugières L; Gardes M; Moutou C; Chompret A; Meresse V; Martin A; Poisson N; Flamant F; Bonaïti-Pellié C; Lemerle J
    Cancer Res; 1993 Feb; 53(3):452-5. PubMed ID: 8425176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer.
    Jolly KW; Malkin D; Douglass EC; Brown TF; Sinclair AE; Look AT
    Oncogene; 1994 Jan; 9(1):97-102. PubMed ID: 8302608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.
    Avigad S; Barel D; Blau O; Malka A; Zoldan M; Mor C; Fogel M; Cohen IJ; Stark B; Goshen Y; Stein J; Zaizov R
    Oncogene; 1997 Apr; 14(13):1541-5. PubMed ID: 9129144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.
    Eeles RA; Warren W; Knee G; Bartek J; Averill D; Stratton MR; Blake PR; Tait DM; Lane DP; Easton DF
    Oncogene; 1993 May; 8(5):1269-76. PubMed ID: 8479749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
    Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of significant germ line p53 mutations in ovarian cancer patients.
    Buller RE; Skilling JS; Kaliszewski S; Niemann T; Anderson B
    Gynecol Oncol; 1995 Sep; 58(3):368-74. PubMed ID: 7672703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
    Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA
    Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.